CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Contraception - emergency - Management
What products and methods are not recommended for emergency contraception?
- The levonorgestrel-releasing intrauterine system should not be used for emergency contraception. It is not licensed in the UK for this indication, and there is no evidence that it is effective for emergency contraception.
- Mifepristone is a progesterone antagonist that has been shown to be an effective emergency contraceptive agent. However, it is not licensed in the UK for this indication and is used only in research.
© NHS Institute for Innovation and Improvement